Literature DB >> 16341702

Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective study.

Nicolas Feltgen1, Julia Herrmann, Hansjuergen Agostini, Adel Sammain, Lutz L Hansen.   

Abstract

PURPOSE: The rationale for this pilot study was to add arterio-venous dissection (AVD) after unsuccessful medical treatment in a well-defined group of patients with branch retinal vein occlusion (BRVO).
METHODS: In this prospective, interventional case series 35 consecutive patients with a visual acuity (VA) of 0.4 (logMar) or worse were scheduled for surgery within the first 3 months of the onset of BRVO. The study endpoint was VA 1 year after AVD. Secondary study endpoints were: correlation of VA and successful vessel dissection; complication rate; and number of additional surgical procedures within the first year of AVD.
RESULTS: Preoperative VA (logMar) was 0.82+/-0.05 (range 0.2-1.6). VA 6 weeks postoperatively was 0.54+/-0.06 (range 0-1.6), 3 months postoperatively 0.61+/-0.07 (0-1.56), 6 months postoperatively 0.74+/-0.08 (range 0-2) and 12 months postoperatively 0.55+/-0.07 (range 0.1-1.5). VA improved 1 year after AVD (p=0.0004). An improvement in VA did not depend on successful separation of the artery and the vein. Four patients had a retinal detachment, 19 patients needed cataract surgery within the first year of AVD. A total of 24 additional surgical procedures were needed.
CONCLUSIONS: Patients with BRVO may profit from AVD compared with a historical control group. Visual improvement was found irrespective of the successful dissection of vessels. The cataract formation rate and additional surgery was a shortcoming of the AVD procedure.

Entities:  

Mesh:

Year:  2005        PMID: 16341702     DOI: 10.1007/s00417-005-0171-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  28 in total

1.  Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion.

Authors:  Ulrich Mester; Patrick Dillinger
Journal:  Retina       Date:  2002-12       Impact factor: 4.256

2.  The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion.

Authors:  M T Cahill; P K Kaiser; J E Sears; S Fekrat
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

3.  [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].

Authors:  A Glacet-Bernard; G Coscas; F Lelong; A Chabanel; M Samama; A Taccoen
Journal:  Bull Soc Ophtalmol Fr       Date:  1989-12

4.  Arteriovenous dissection in a living human eye: clinicopathologic correlation.

Authors:  Nicolas Feltgen; Claudia Auw-Haedrich; Renate Buchen; Lutz L Hansen
Journal:  Arch Ophthalmol       Date:  2005-04

5.  [Randomized study of the effect of isovolemic hemodilution in retinal branch vein occlusion].

Authors:  L L Hansen; J Wiek; R Arntz
Journal:  Fortschr Ophthalmol       Date:  1988

6.  Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion.

Authors:  J F Le Rouic; R A Bejjani; F Rumen; C Caudron; O Bettembourg; G Renard; D Chauvaud
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-10       Impact factor: 3.117

7.  Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion.

Authors:  Shuichi Yamamoto; Wataru Saito; Fumihiko Yagi; Shinobu Takeuchi; Eiju Sato; Satoshi Mizunoya
Journal:  Am J Ophthalmol       Date:  2004-12       Impact factor: 5.258

Review 8.  [Retinal vein occlusions].

Authors:  S Dithmar; L L Hansen; F G Holz
Journal:  Ophthalmologe       Date:  2003-07       Impact factor: 1.059

9.  Surgical decompression of branch retinal vein occlusions.

Authors:  M D Osterloh; S Charles
Journal:  Arch Ophthalmol       Date:  1988-10

10.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01
View more
  3 in total

Review 1.  [Arteriovenous dissection for branch retinal vein occlusion].

Authors:  N Feltgen; L-O Hattenbach; A Mirshahi; L Hansen
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

Review 2.  [Surgical treatments for retinal vein occlusion].

Authors:  N Feltgen; H Agostini; L Hansen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

3.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.